A rating of 94 puts Tempest Therapeutics Inc (TPST) near the top of the Biotechnology industry according to InvestorsObserver. Tempest Therapeutics Inc's score of 94 means it scores higher than 94% of stocks in the industry. Tempest Therapeutics Inc also received an overall rating of 77, putting it above 77% of all stocks. Biotechnology is ranked 49 out of the 148 industries.
TPST has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on TPST!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Tempest Therapeutics Inc Stock Today?
Tempest Therapeutics Inc (TPST) stock is trading at $3.79 as of 9:37 AM on Thursday, Nov 9, an increase of $0.97, or 34.4% from the previous closing price of $2.82. The stock has traded between $3.38 and $3.88 so far today. Volume today is low. So far 463,928 shares have traded compared to average volume of 19,701,873 shares.
Click Here to get the full Stock Report for Tempest Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
